News
Following the successful MAPS study, MDMA-assisted therapy moves closer to becoming approved by the US FDA
Hi, what are you looking for?
Following the successful MAPS study, MDMA-assisted therapy moves closer to becoming approved by the US FDA
Aside from impairment testing, Ontario-based Zentrela wants to work with cannabis producers to generate accurate product claims
Study aims to prove safety of psilocybe mushrooms so Canadian regulators can expand access to psychedelic therapy
Identifying specific terpene-cannabinoid combinations can create new ways to improve medical therapy, researchers suggest
More alcohol, but not weed, use during youth is associated with thinning in parts of the brain associated with intelligence, impulsivity and risky behaviour
The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine
The resource-rich country produces less emissions than the US, but it's still a big problem that government isn't tracking and firms don't want to...
Canadian provinces are slowly easing strict marketing rules to be on par with alcohol and meet broader public policy goals, U of A prof...
It's essential to test products pre-launch as they can create bad consumer experiences, says Nextleaf Solutions, which just got approved for human trials
Early evidence shows LSD promotes social behaviour in rodents, but pharmaceutical research is still a ways off
